Cargando…
Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
People with Down syndrome (DS) are at high risk of developing Alzheimer disease (AD) with aging. The diagnosis and treatment trials are hampered by a lack of reliable blood biomarkers. Plasma neurofilament light chain (NfL) is one of the established biomarkers of AD, suggesting that it may be useful...
Autores principales: | Shinomoto, Makiko, Kasai, Takashi, Tatebe, Harutsugu, Kondo, Masaki, Ohmichi, Takuma, Morimoto, Masafumi, Chiyonobu, Tomohiro, Terada, Naoto, Allsop, David, Yokota, Isao, Mizuno, Toshiki, Tokuda, Takahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450630/ https://www.ncbi.nlm.nih.gov/pubmed/30951523 http://dx.doi.org/10.1371/journal.pone.0211575 |
Ejemplares similares
-
Increased levels of plasma total tau in adult Down syndrome
por: Kasai, Takashi, et al.
Publicado: (2017) -
Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021) -
Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2018) -
Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
por: Kasai, Takashi, et al.
Publicado: (2019) -
Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)